Rhumbline Advisers Immutep LTD Transaction History
Rhumbline Advisers
- $109 Billion
- Q4 2024
A detailed history of Rhumbline Advisers transactions in Immutep LTD stock. As of the latest transaction made, Rhumbline Advisers holds 28,727 shares of IMMP stock, worth $60,326. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,727
Previous 29,497
2.61%
Holding current value
$60,326
Previous $65,000
4.62%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IMMP
# of Institutions
32Shares Held
2MCall Options Held
264KPut Options Held
90.5K-
Black Rock Inc. New York, NY839KShares$1.76 Million0.0% of portfolio
-
Meridian Wealth Management, LLC398KShares$836,7450.04% of portfolio
-
Xy Capital LTD Central, K3165KShares$345,7750.17% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA113KShares$236,2560.0% of portfolio
-
Jane Street Group, LLC New York, NY80.5KShares$169,0260.0% of portfolio
About IMMUTEP Ltd
- Ticker IMMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,000
- Market Cap $182M
- Description
- Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...